Penumbra, Inc.

PENNYSEUSD
320.94 USD
0.31 (0.10%)🟢PRE MARKET (AS OF 08:04 AM EDT)
🟢Market: OPEN
Open?$320.68
High?$320.94
Low?$320.63
Prev. Close?$320.63
Volume?386
Avg. Volume?451.8K
VWAP?$320.79
Rel. Volume?0.00x
Bid / Ask
Bid?$319.89 × 360
Ask?$321.86 × 160
Spread?$1.97
Midpoint?$320.88
Valuation & Ratios
Market Cap?12.6B
Shares Out?39.3M
Float?38.0M
Float %?96.9%
P/E Ratio?73.73
P/B Ratio?8.56
EPS?$4.35
Dividend?0.00%
Ex-Dividend?N/A

Shares of Penumbra, Inc. (PEN) are trading at $320.94. The stock presents a mixed profile: our models indicate a Buy for underlying fundamentals, while technical indicators flash a Sell. Key drivers include a robust Altman Z-Score and a bullish Golden Cross on the moving averages. Furthermore, PEN is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Jun 4, 2026.

RelatedLNTHITGR
News
Profile
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
Employees
4.7K
Market Cap
12.6B
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2015-09-18
Address
ONE PENUMBRA PLACE
ALAMEDA, CA 94502
Phone: (510) 995-2486
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-1/3)
Medium-Term (Wave)? Bearish(-1/3)
Short-Term (Ripple)? Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
100
Momentum?
83
Short Sent.?
49
Piotroski F-Score?5/9Mixed
Altman Z-Score?19.78Safe
Confidence?69%Moderate
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?5.04%Elevated
Short Interest?1.9M
Days to Cover?4.7
Free Float38.0M
Avg Daily Volume411.9K
Settlement Date2026-05-15
Financial Health
Current Ratio?6.02Strong
Quick Ratio?3.95Strong
Cash Ratio?1.14Strong
Debt/Equity?0.02Low
ValuationRICHLY VALUEDvs 2 peers + S&P 500
Score
33/100
P/E?
Peers
33
S&P
6
73.7PRICEY
P/B?
Peers
33
S&P
22
8.56HIGH
P/S?
Peers
33
S&P
10
8.67HIGH
P/FCF?
Peers
33
S&P
8
59.3PRICEY
EV/EBITDA?
Peers
33
S&P
3
60.7HIGH
EV/Sales?
Peers
33
S&P
15
8.52HIGH
Returns & Efficiency
ROE?
Peers
67
S&P
41
11.6%FAIR
ROA?
Peers
67
S&P
71
9.0%STRONG
Cash Flow & Enterprise
FCF?$212.7M
Enterprise Value?$12.4B
Fundamentals ratios updated end of day